Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicentre Multinational Prospective Randomised Double-blind Placebo-controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport® in Patients With Upper Back Myofascial Pain Syndrome

NCT00134810 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00134810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00134810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicentre Multinational Prospective Randomised Double-blind Placebo-controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport® in Patients With Upper Back Myofascial Pain Syndrome
Lead sponsor
Ipsen
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2005
Completion date
May 18, 2006
Enrollment
381 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pain syndromes